Molecular epidemiology of MRSA in 13 ICUs from eight European countries

February 14, 2016 at 7:43 pm

Journal of Antimicrobial and Chemotherapy January 2016 V.71 N.1 P.45-52

Editor’s Choice

J. Hetem, L. P. G. Derde, J. Empel, A. Mroczkowska, M. Orczykowska-Kotyna, A. Kozińska, W. Hryniewicz, H. Goossens, and M. J. M. Bonten on behalf of the MOSAR WP3 Study Group

1Department of Clinical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands

2Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

3Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland

4Department of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium

5Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands

Rigorous screening of carriage of MRSA, rather than relying on clinical isolates, together with standardized methods and centralized genotyping allowed for a more comprehensive and complete estimation of the prevalence and epidemiology of the isolates in the ICUs involved in the study.

abstract

http://jac.oxfordjournals.org/content/71/1/45.abstract

PDF

http://jac.oxfordjournals.org/content/71/1/45.full.pdf

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Biología Molecular, Epidemiología, Health Care-Associated Infections, Infecciones nosocomiales, Metodos diagnosticos, Resistencia bacteriana, Sepsis, Update. Tags: .

A systematic review of the public’s knowledge and beliefs about antibiotic resistance Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST


Calendar

February 2016
M T W T F S S
« Jan   Mar »
1234567
891011121314
15161718192021
22232425262728
29  

Most Recent Posts


%d bloggers like this: